ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients

Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in si...

Full description

Saved in:
Bibliographic Details
Published inJournal of pathology and translational medicine Vol. 47; no. 5; pp. 452 - 457
Main Authors Lee, Cheol, Park, Jeong Whan, Suh, Ja Hee, Nam, Kyung Han, Moon, Kyung Chul
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Pathologists, Korean Society for Cytopathology 01.10.2013
The Korean Society of Pathologists and The Korean Society for Cytopathology
대한병리학회
Subjects
Online AccessGet full text
ISSN1738-1843
2383-7837
2092-8920
2383-7845
DOI10.4132/KoreanJPathol.2013.47.5.452

Cover

Loading…
Abstract Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.
AbstractList Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. Methods: We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. Results: One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. Conclusions: We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. KCI Citation Count: 0
Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.
Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases. We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases. One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin. We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis. [PUBLICATION ABSTRACT]
Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.BACKGROUNDRecently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.METHODSWe screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.RESULTSOne ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.CONCLUSIONSWe found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.
Author Nam, Kyung Han
Moon, Kyung Chul
Suh, Ja Hee
Park, Jeong Whan
Lee, Cheol
AuthorAffiliation 1 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
2 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 2 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
– name: 1 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Cheol
  surname: Lee
  fullname: Lee, Cheol
  organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Jeong Whan
  surname: Park
  fullname: Park, Jeong Whan
  organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Ja Hee
  surname: Suh
  fullname: Suh, Ja Hee
  organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Kyung Han
  surname: Nam
  fullname: Nam, Kyung Han
  organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Kyung Chul
  surname: Moon
  fullname: Moon, Kyung Chul
  organization: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea., Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24255633$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001813263$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqNUl1rFDEUDVKx2-pfkEBffJkx3zNBEJbFj9oFS63PIZvJtGlnkzWZKfTfe3fXqi0--JJLyDnnnntzjtBBTNEjdEJJLShnb89S9jZ-ObfjdRpqRiivRVPLWkj2DM0Y0axqNSMHaEYb3la0FfwQHZVyQ4gSQpEX6JAJJqXifIbyfHlWnacSxnDn8YWPdsALP8BhswsxrS0OEVu8tPnK428-B19w6vEixeLdtGUN98CDy-g7vPf2bx0wHHwcy0v0vLdD8a9-1WP0_eOHy8Xnavn10-livqwceBurvuv1ynErqGp930puG9orqyQRK017TXQnmFeOcsGJbjmMqTrbNFqJ1ktgHqM3e92Ye3Prgkk27OpVMrfZzC8uT03LtGoEQN_voZtptfadA5vZDmaTw9rm-x3x8UsM1yBzZ3gLvTX702uT04_Jl9GsQ3Ewv40-TcVQoeBLZCMpQE-eQG_SlGFfOxRhnDWaA-r1345-W3n4OQDM9wCXUynZ98aFETactgbDYCgx27SYR2kx27QY0RhpIC2g8e6JxkOb_2H_BNqCygQ
CitedBy_id crossref_primary_10_1016_j_prp_2019_152669
crossref_primary_10_1016_j_prp_2025_155814
crossref_primary_10_3349_ymj_2020_61_3_262
crossref_primary_10_1097_MD_0000000000016702
crossref_primary_10_1002_gcc_22346
crossref_primary_10_1038_s41379_021_00737_6
crossref_primary_10_1097_PAP_0000000000000138
crossref_primary_10_1016_j_mpdhp_2016_01_005
crossref_primary_10_1097_PAS_0000000000000610
crossref_primary_10_1002_gcc_22382
crossref_primary_10_1038_s41379_020_0578_0
crossref_primary_10_3390_ijms23073995
crossref_primary_10_1016_j_eururo_2018_03_032
crossref_primary_10_1016_j_prp_2016_07_015
crossref_primary_10_1111_his_13185
crossref_primary_10_1016_j_modpat_2024_100536
crossref_primary_10_1186_s13000_019_0879_0
crossref_primary_10_1016_j_prp_2019_152651
crossref_primary_10_1111_his_13727
crossref_primary_10_1016_j_prp_2020_153286
crossref_primary_10_1186_s12885_018_4066_6
crossref_primary_10_1097_PAS_0000000000001476
crossref_primary_10_1111_pin_12592
crossref_primary_10_3390_cancers12010168
crossref_primary_10_1007_s13277_015_3977_y
crossref_primary_10_1016_j_cancergen_2017_11_010
crossref_primary_10_3390_cancers12010085
crossref_primary_10_1016_j_prp_2016_07_004
crossref_primary_10_1007_s00428_020_02752_5
Cites_doi 10.1016/j.semcancer.2011.09.005
10.1007/s00428-011-1127-5
10.1126/science.8122112
10.1097/JTO.0b013e31820b82e8
10.1002/cncr.27391
10.1200/JCO.2005.07.055
10.1056/NEJMoa1006448
10.1097/JTO.0b013e318274a83e
10.1016/j.prp.2011.07.001
10.4143/crt.2013.45.1.1
10.1097/CCO.0b013e328351c646
10.1038/modpathol.2012.107
10.1371/journal.pone.0018436
10.1038/modpathol.2010.213
10.1056/NEJMoa1007056
10.1016/j.lungcan.2011.11.008
10.1073/pnas.0609412103
10.1097/JTO.0b013e31821cfc73
10.1097/00000478-200111000-00003
10.1002/gcc.20839
10.1200/JCO.2008.21.5020
10.1038/nature07399
ContentType Journal Article
Copyright Copyright Korean Society of Pathologists, Korean Society for Cytopathology Oct 2013
2013 The Korean Society of Pathologists/The Korean Society for Cytopathology 2013
Copyright_xml – notice: Copyright Korean Society of Pathologists, Korean Society for Cytopathology Oct 2013
– notice: 2013 The Korean Society of Pathologists/The Korean Society for Cytopathology 2013
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
BVBZV
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ACYCR
DOI 10.4132/KoreanJPathol.2013.47.5.452
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest East & South Asia Database (NC LIVE)
ProQuest One Community College
ProQuest Central
ProQuest Central Student
Research Library Prep
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
East & South Asia Database
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-8920
2383-7845
EndPage 457
ExternalDocumentID oai_kci_go_kr_ARTI_829674
PMC3830992
3132815151
24255633
10_4132_KoreanJPathol_2013_47_5_452
Genre Journal Article
Feature
GrantInformation_xml – fundername: Seoul University Hospital
  grantid: 03-2010-009
GroupedDBID 5-W
5GY
8G5
8JR
9ZL
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BVBZV
CITATION
DIK
DWQXO
EF.
ESX
GNUQQ
GUQSH
HYE
KQ8
M2O
M48
PGMZT
RNS
RPM
TUS
NPM
OK1
3V.
7XB
8FK
ACYCR
AFKRA
AZQEC
BCNDV
CCPQU
GROUPED_DOAJ
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
PROAC
Q9U
7X8
5PM
IPNFZ
M~E
RIG
ID FETCH-LOGICAL-c556t-fdf9bc3a4168ef853a71f6a6504b91f909d42e6c134309838436da779648e5bc3
IEDL.DBID M48
ISSN 1738-1843
2383-7837
IngestDate Tue Nov 21 21:39:55 EST 2023
Thu Aug 21 18:04:39 EDT 2025
Fri Jul 11 06:54:05 EDT 2025
Mon Jun 30 02:44:05 EDT 2025
Thu Jan 02 22:12:28 EST 2025
Tue Jul 01 00:30:30 EDT 2025
Thu Apr 24 23:10:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords ALK
Immunohistochemistry
In situ hybridization, fluorescence
Carcinoma, renal cell
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c556t-fdf9bc3a4168ef853a71f6a6504b91f909d42e6c134309838436da779648e5bc3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
G704-000333.2013.47.5.010
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4132/KoreanJPathol.2013.47.5.452
PMID 24255633
PQID 1460232793
PQPubID 1146335
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_829674
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3830992
proquest_miscellaneous_1469205751
proquest_journals_1460232793
pubmed_primary_24255633
crossref_citationtrail_10_4132_KoreanJPathol_2013_47_5_452
crossref_primary_10_4132_KoreanJPathol_2013_47_5_452
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-10-01
PublicationDateYYYYMMDD 2013-10-01
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Journal of pathology and translational medicine
PublicationTitleAlternate Korean J Pathol
PublicationYear 2013
Publisher Korean Society of Pathologists, Korean Society for Cytopathology
The Korean Society of Pathologists and The Korean Society for Cytopathology
대한병리학회
Publisher_xml – name: Korean Society of Pathologists, Korean Society for Cytopathology
– name: The Korean Society of Pathologists and The Korean Society for Cytopathology
– name: 대한병리학회
References Mariño-Enríquez (10.4132/KoreanJPathol.2013.47.5.452_ref19) 2011; 50
Laurent (10.4132/KoreanJPathol.2013.47.5.452_ref6) 2009; 27
Azarova (10.4132/KoreanJPathol.2013.47.5.452_ref14) 2011; 21
Patard (10.4132/KoreanJPathol.2013.47.5.452_ref3) 2005; 23
Jung (10.4132/KoreanJPathol.2013.47.5.452_ref1) 2013; 45
Conklin (10.4132/KoreanJPathol.2013.47.5.452_ref24) 2013; 8
Eble (10.4132/KoreanJPathol.2013.47.5.452_ref2) 2004
Kwak (10.4132/KoreanJPathol.2013.47.5.452_ref10) 2010; 363
Sugawara (10.4132/KoreanJPathol.2013.47.5.452_ref21) 2012; 118
Kim (10.4132/KoreanJPathol.2013.47.5.452_ref15) 2011; 6
Chen (10.4132/KoreanJPathol.2013.47.5.452_ref9) 2008; 455
Morris (10.4132/KoreanJPathol.2013.47.5.452_ref5) 1994; 263
Butrynski (10.4132/KoreanJPathol.2013.47.5.452_ref11) 2010; 363
Wang (10.4132/KoreanJPathol.2013.47.5.452_ref7) 2011; 207
Debelenko (10.4132/KoreanJPathol.2013.47.5.452_ref18) 2011; 24
Paik (10.4132/KoreanJPathol.2013.47.5.452_ref16) 2011; 6
Kim (10.4132/KoreanJPathol.2013.47.5.452_ref22) 2011; 459
Singer (10.4132/KoreanJPathol.2013.47.5.452_ref4) 2012; 24
Cerchietti (10.4132/KoreanJPathol.2013.47.5.452_ref13) 2011; 6
Edge (10.4132/KoreanJPathol.2013.47.5.452_ref23) 2010
Sukov (10.4132/KoreanJPathol.2013.47.5.452_ref20) 2012; 25
Galkin (10.4132/KoreanJPathol.2013.47.5.452_ref12) 2007; 104
Paik (10.4132/KoreanJPathol.2013.47.5.452_ref17) 2012; 76
Cook (10.4132/KoreanJPathol.2013.47.5.452_ref8) 2001; 25
21587085 - J Thorac Oncol. 2011 Aug;6(8):1359-66
17185414 - Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5
21494621 - PLoS One. 2011 Apr 08;6(4):e18436
20979469 - N Engl J Med. 2010 Oct 28;363(18):1693-703
19636007 - J Clin Oncol. 2009 Sep 1;27(25):4211-6
21213368 - Genes Chromosomes Cancer. 2011 Mar;50(3):146-53
8122112 - Science. 1994 Mar 4;263(5151):1281-4
23196275 - J Thorac Oncol. 2013 Jan;8(1):45-51
23613665 - Cancer Res Treat. 2013 Mar;45(1):1-14
18923524 - Nature. 2008 Oct 16;455(7215):971-4
21258247 - J Thorac Oncol. 2011 Mar;6(3):466-72
21076462 - Mod Pathol. 2011 Mar;24(3):430-42
22743654 - Mod Pathol. 2012 Nov;25(11):1516-25
22129856 - Lung Cancer. 2012 Jun;76(3):403-9
21945349 - Semin Cancer Biol. 2011 Oct;21(4):267-75
11684952 - Am J Surg Pathol. 2001 Nov;25(11):1364-71
21773754 - Virchows Arch. 2011 Sep;459(3):299-306
21855232 - Pathol Res Pract. 2011 Sep 15;207(9):587-91
22343386 - Curr Opin Oncol. 2012 May;24(3):284-90
15837991 - J Clin Oncol. 2005 Apr 20;23(12):2763-71
20979472 - N Engl J Med. 2010 Oct 28;363(18):1727-33
22252991 - Cancer. 2012 Sep 15;118(18):4427-36
References_xml – volume: 21
  start-page: 267
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref14
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2011.09.005
– volume: 459
  start-page: 299
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref22
  publication-title: Virchows Arch
  doi: 10.1007/s00428-011-1127-5
– volume-title: AJCC cancer staging manual
  year: 2010
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref23
– volume: 263
  start-page: 1281
  year: 1994
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref5
  publication-title: Science
  doi: 10.1126/science.8122112
– volume: 6
  start-page: 466
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref16
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e31820b82e8
– volume: 118
  start-page: 4427
  year: 2012
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref21
  publication-title: Cancer
  doi: 10.1002/cncr.27391
– start-page: 12
  volume-title: Pathology and genetics of tumours of the urinary system and male genital organs
  year: 2004
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref2
– volume: 23
  start-page: 2763
  year: 2005
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref3
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.07.055
– volume: 363
  start-page: 1693
  year: 2010
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref10
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1006448
– volume: 8
  start-page: 45
  year: 2013
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref24
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318274a83e
– volume: 207
  start-page: 587
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref7
  publication-title: Pathol Res Pract
  doi: 10.1016/j.prp.2011.07.001
– volume: 45
  start-page: 1
  year: 2013
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref1
  publication-title: Cancer Res Treat
  doi: 10.4143/crt.2013.45.1.1
– volume: 24
  start-page: 284
  year: 2012
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref4
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0b013e328351c646
– volume: 25
  start-page: 1516
  year: 2012
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref20
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2012.107
– volume: 6
  start-page: e18436
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0018436
– volume: 24
  start-page: 430
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref18
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2010.213
– volume: 363
  start-page: 1727
  year: 2010
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1007056
– volume: 76
  start-page: 403
  year: 2012
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref17
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2011.11.008
– volume: 104
  start-page: 270
  year: 2007
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref12
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0609412103
– volume: 6
  start-page: 1359
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref15
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e31821cfc73
– volume: 25
  start-page: 1364
  year: 2001
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref8
  publication-title: Am J Surg Pathol
  doi: 10.1097/00000478-200111000-00003
– volume: 50
  start-page: 146
  year: 2011
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref19
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20839
– volume: 27
  start-page: 4211
  year: 2009
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref6
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.21.5020
– volume: 455
  start-page: 971
  year: 2008
  ident: 10.4132/KoreanJPathol.2013.47.5.452_ref9
  publication-title: Nature
  doi: 10.1038/nature07399
– reference: 23613665 - Cancer Res Treat. 2013 Mar;45(1):1-14
– reference: 8122112 - Science. 1994 Mar 4;263(5151):1281-4
– reference: 19636007 - J Clin Oncol. 2009 Sep 1;27(25):4211-6
– reference: 21076462 - Mod Pathol. 2011 Mar;24(3):430-42
– reference: 21213368 - Genes Chromosomes Cancer. 2011 Mar;50(3):146-53
– reference: 21855232 - Pathol Res Pract. 2011 Sep 15;207(9):587-91
– reference: 22743654 - Mod Pathol. 2012 Nov;25(11):1516-25
– reference: 21773754 - Virchows Arch. 2011 Sep;459(3):299-306
– reference: 21587085 - J Thorac Oncol. 2011 Aug;6(8):1359-66
– reference: 23196275 - J Thorac Oncol. 2013 Jan;8(1):45-51
– reference: 20979472 - N Engl J Med. 2010 Oct 28;363(18):1727-33
– reference: 17185414 - Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):270-5
– reference: 15837991 - J Clin Oncol. 2005 Apr 20;23(12):2763-71
– reference: 11684952 - Am J Surg Pathol. 2001 Nov;25(11):1364-71
– reference: 18923524 - Nature. 2008 Oct 16;455(7215):971-4
– reference: 21258247 - J Thorac Oncol. 2011 Mar;6(3):466-72
– reference: 22129856 - Lung Cancer. 2012 Jun;76(3):403-9
– reference: 21945349 - Semin Cancer Biol. 2011 Oct;21(4):267-75
– reference: 20979469 - N Engl J Med. 2010 Oct 28;363(18):1693-703
– reference: 22252991 - Cancer. 2012 Sep 15;118(18):4427-36
– reference: 22343386 - Curr Opin Oncol. 2012 May;24(3):284-90
– reference: 21494621 - PLoS One. 2011 Apr 08;6(4):e18436
SSID ssj0064460
ssj0001453649
Score 2.0798368
Snippet Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened...
Background: Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 452
SubjectTerms Genes
Original
Patients
Pediatrics
Studies
병리학
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZoKyEuCMRroSAjuHq7iR9xuKBStSptqVYVlXqzHD9gu1un7KNS_z0zSXbLogpxSQ7xWHZmPPONPZ4h5KMVbjCIumKc-4IJ5xWrooys8oXC6rZWN7fSvp2qw3NxdCEvug23WRdWudSJjaL2tcM98h1Y0WBechCnz9e_GFaNwtPVroTGBtkCFaxBzre-7J8Oz-52WYTkqsHAYJo4K8Ade0g-gKYA3Z3vjGsAZukSa__WeAyR8b4o-rIvZL5mpjbSNN6HQP8OpPzDMh08IY87SEl3Wxl4Sh6E9IxMd0-O2bCJyLoJ9Cxgi70wgQcWD0r1laWjRC09wUhwintkYUbrSLGAZ3ALpJrcUozLc4BJ6XEzh_v7GbapWWfPyfnB_ve9Q9bVV2BOSjVn0ceyctwCJtMhgt22RRaVBcwmqjKL5aD0Ig_KZVzwQam5Flx5W-DlVR0kUL4gm6lO4RWhIq-8thkWLYtAoy1wqgJfyAcPCCbEHvm0_J3GdcnHsQbGxIATgrww7TyOhg0vDPLCiMJIA7zoEbEivm5zcPwf2Xvgmxm7kcEc2vj-UZvx1ICn8NXovFSF6JHtJVdNt3hn5k7UoIvVZ1h2eJZiU6gXTZsyR6yb9cjLVghWY0MvTioO1MWaeKwa4HDWv6TRzya1NwgpQPb89b-H9YY8wpm2MYXbZHM-XYS3gI3m1btuAfwGVdQOpA
  priority: 102
  providerName: ProQuest
Title ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/24255633
https://www.proquest.com/docview/1460232793
https://www.proquest.com/docview/1469205751
https://pubmed.ncbi.nlm.nih.gov/PMC3830992
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001813263
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Pathology and Translational Medicine, 2013, 47(5), , pp.452-457
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTZp4QXwTGJURvCY0sRMnvKAxbRrbOlUTlfZmObEN1UoCaYvYf89dvkRRHyZekgf7LPvubP_OPt8BvNOiGI9dmvucG-mLwiR-7mLn50YmlN1Wp82rtMllcjoTZ9fx9Q704Qk6Bi63mnaUT2pWL4LfP28_4oRH_BrgEhy9P68QX5VnU00HieStxQMhgzgQMa7Ne7hFJWSVTcRwvYAYoH0-LHG2U8KTfXh7h8YocLCgkF2cb-xi98rabQOo__pZ_rVxnTyEBx3iZIetijyCHVs-hv1Jd6f-BOrDi3N_2vhu_bLsylLlI7vAD6UZKqvvms1LptkF-YwzOk2zS1Y5Rqk-bbEmqsUtIw--AtEra0e2vZ1pG8R1-RRmJ8dfjk79LhODX-BwV74zLssLrpGVqXW4w2sZukQjuhN5FrpsnBkR2aQIueDjLOXI0sRoSc9cUxsj5TPYLavSvgAmotykOqT0Zg5pUs0jmaPVZKxBrGOdBx96zqqiC1NO2TIWCs0VkpDakJAiCSkhVaxQQh6IgfhHG63jbmRvUITqppgrirZN_6-VuqkV2hSfVRpliRQeHPQCVr2Wkt2EmCfCNQ6bGIpxgtKtiy5ttW7qZBGh4tCD560-DH3r1ckDuaEpQwXqzmZJOf_WBAHnKXI6i17-N-UruE9MaB0TD2B3Va_tawRYq3wEe5-OL6dXo-aAYtRMnVFzDvYHaLEnqA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9tnQS8IBBfhQFGwGO6xnacBAmhMTa1a1dV0ybtzXMSG0pLMvoB2j_F38hd0nQUTYiXvSQP9lm27-z7nX2-A3hjZNpuuyjxhMhCT6aZ8hIXOC_JQkXZbU1Uvko7GqjOqTw8C8424Ff9FobcKus9sdyosyKlM_IdXNGoXjiK04eL7x5ljaLb1TqFRiUWPXv5E0222fvuJ-TvW84P9k_2Ot4yq4CXBoGaey5zcZIKg0gksg61lQl9pwwiFZnEvovbcSa5VakvpGjHkYikUJkJ6clmZAOkxHY3YUvSi9YGbH3cHwyPr051ZCBUiblRFQovRPPvFrzGnQl1Bd8ZFwgE86-Ua7igaw9ftGTYCloy4GtqcTOfuusQ79-Om39owoN7cHcJYdluJXP3YcPmD2C62-95w9ID7Idlx5Zq7NkJfihZUV58M2yUM8P65HnO6EzOzljhGCUMtemCqCaXjPwAU8TArFeO4fp2hlUo2NlDOL2RmX8EjbzI7RNgkidZZHxKkuaQJjIoGQnaXpnNEDFZ14R39XTqdBnsnHJuTDQaPcQLXY3jcFjyQhMvtAx1oJEXTZAr4osq5sf_kb1CvulxOtIUs5v-nws9nmq0TLo64rEKZRO2a67q5WYx01eijU2sinGZ092NyW2xKOvEnLC134THlRCs-kZWY6AEUodr4rGqQN1ZL8lHX8pQ4iikaCLwp__u1ku43Tk56ut-d9B7Bndo1JU_4zY05tOFfY64bJ68WC4GBuc3vf5-A09ISnk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JbxMxFLbaVKq4sIgtUMAIOE6S8TYzSAh1IWqaUEWIVlUvZsZjQ0mYKVlA5afxV_gzvDdLSqoKcemBy8zBfpaXz2-xn98j5HksTKfjwsTjPA08YVLlJU46L0kDhdlt47B4lfZ2X-0eiL0jebRCftZvYdCtsuaJBaNOc4Nn5G3Y0SBeGMCp7Sq3iOFO9_XpVw8zSOFNa51Oo4RI3559B_Nt-qq3A2v9grHum_fbu16VYcAzUqqZ51IXJYbHoJWE1oHkigPfqRi0FpFEvos6USqYVcbngneikIeCqzQO8PlmaCVQQrurZC1UoWQNsrZ1uHV8eH7CIyRXhf4NYpF7AZiC6-QZcCmQG6w9ykEpzD5j3uEcr0B83hJBS7aEZEsicjWbuMu034tOnH9Ixe4N8quez9IZZtSaz5KW-XEh1OT_OeE3yfVKWaeb5e66RVZsdptMNgd9b1j4un2z9J3FGtt2DB9My5TlX2J6ktGYDtDHnuLpo53S3FFMjWrNHKnGZxQ9Hg1o-7RfrNDl7QzLoLfTO-TgSoZ5lzSyPLP3CRUsScPYx3RwDmjCGJYkASsztSnohtY1ycsaLNpUYd0xu8hYg3mHSNPlOPaGBdI0Ik2LQEsNSGsSsSA-LaOb_BvZU0ClHpkTjdHJ8f8x16OJBhusp0MWqUA0yUYNK12xxak-xxQ0sSgGhoa3VHFm83lRJ2JoRfhNcq-E-KJvaB9LxYE6WAL_ogJ2Z7kkO_lUBE2HLQjGEHvw9249IesAcj3o7fcfkms46NJxc4M0ZpO5fQQK6Cx5XO10Sj5cNdZ_A9ORlcI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ALK-Positive+Renal+Cell+Carcinoma+in+a+Large+Series+of+Consecutively+Resected+Korean+Renal+Cell+Carcinoma+Patients&rft.jtitle=The+Korean+journal+of+pathology&rft.au=Lee%2C+Cheol&rft.au=Park%2C+Jeong+Whan&rft.au=Suh%2C+Ja+Hee&rft.au=Nam%2C+Kyung+Han&rft.date=2013-10-01&rft.pub=The+Korean+Society+of+Pathologists+and+The+Korean+Society+for+Cytopathology&rft.issn=1738-1843&rft.eissn=2092-8920&rft.volume=47&rft.issue=5&rft.spage=452&rft.epage=457&rft_id=info:doi/10.4132%2FKoreanJPathol.2013.47.5.452&rft_id=info%3Apmid%2F24255633&rft.externalDocID=PMC3830992
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-1843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-1843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-1843&client=summon